Navigate on publiceye.ch
Quick navigation
Content
Homepage
Navigation
Sitemap
Search
Main navigation
About us
Get involved
Our topics
Change category
#toxicexports
Pesticides
Commodities
Soft Commodities
Fashion
Medicines
Trade policy
Investigation Award
Seeds
Biopiracy
Archive
Close
Open search forn
Publications
en
Change language. Current language: English
Deutsch
Français
English
Close
Donate
Open menu
Search term
Search
Close search
Search term
Search
About us
Get involved
Our topics
Pesticides
Commodities
Soft Commodities
Fashion
Medicines
Trade policy
Investigation Award
Seeds
Biopiracy
Archive
Publications
Change language. Current language: English
DE
FR
EN
Close menu
Tag
Medicines
Affordable drugs
How dare you, Novartis?
28 February 2020
Victory for public health
Novartis drops the Kymriah patent that was opposed by Public Eye
16 December 2019
Affordable drugs
Novartis cancer treatment for CHF 370,000?! Public Eye opposes Kymriah patent
3 July 2019
Report
Post-Trial Access to Swiss Medicines
2019
Clinical trials
Roche and Novartis neglect their ethical responsibility in emerging countries
20 May 2019
Panel discussion
No fair pricing without transparency
11 April 2019
News
Stop TRIPS-plus measures in trade agreement with Indonesia
6 November 2018
Press Release
33,000 signatures: curb the exorbitant cost of medicines
13 September 2018
Report
Protect patients, not patents
2018
Press Release
Compulsory licensing in Colombia: Aggressive lobbying by Novartis
12 April 2017
1
2
3
4
Your continued use of our website implies that you acknowledge the use of cookies.
More infos about this in our privacy statement.